Liraglutide is a GLP-1 RA that's intended for treating type 2 diabetes, but it can moderately help with weight loss. It's marketed as Saxenda and Victoza. Tirzepatide is a dual GIP/GLP-1 RA that has enhanced blood sugar and weight loss control. It's sold as Mounjaro and Zepbound.
Both liraglutide and tirzepatide have been shown to cause gastroparesis, vision loss, bowel obstruction, ileus, and long-term vomiting.
Both medications are heavily marketed as weight loss and type 2 diabetes drugs, but their manufacturers have withheld the fact that they can also cause serious health conditions. If you have used liraglutide or tirzepatide, and were diagnosed afterward with a linkable disease, we encourage you to reach out to our experts, and we'll check if you're eligible for a claim. If you meet the requirements you'll be reffered to an attorney specializing in these types of cases and who will file the claim on your behalf.